Elder Care Assistive Robots Market

Publisher Grand View Research

Published Jan 09, 2026

Length 150 Pages

SKU # GV20873139

Description

Elder Care Assistive Robots Market Summary

The global elder care assistive robots market size was estimated at USD 3.38 billion in 2025 and is projected to reach USD 9.85 billion by 2033, growing at a CAGR of 14.20% from 2026 to 2033. The rising geriatric population, growing investments, and increasing shortage of care givers is driving the demand for elder care-assistive robots.

As populations across the globe continue to age at an unprecedented rate, the demand for elder care services is surging. With advancements in healthcare leading to increased life expectancy, many countries particularly those within the OECD are facing significant pressure to provide adequate care and support for their growing elderly populations. This demographic shift is reshaping social and economic structures and exposing critical gaps in healthcare systems. For instance, according to the Global Coalition on Aging Report in 2021, there will be a shortage of 13.5 million care workers by 2040 across OECD countries alone, which represents a 60% increase needed in the current workforce to maintain the present ratio of caregivers to patients. This growing gap is propelling the need for innovative solutions to support the elderly, thereby fostering market growth.

The growing investment by government and non-government bodies will boost market growth. In August 2023, Intuition Robotics, a company specializing in technology for seniors, raised USD 25 million to address the increasing interest in ElliQ, its conversational AI-powered robot designed for seniors. The device uses generative AI and large language models (LLMs) to facilitate ongoing conversational interactions between the robot and its user. Furthermore, increasing integration of artificial intelligence (AI) in the eldercare robots are enhancing their features, thereby fostering its adoptions. In March 2024, a South Korean company called Hyodol created a robot that utilizes AI to interact with elderly individuals living with dementia. This robot has advanced language-processing abilities, emotional recognition, and can talk and play music, providing companionship to lonely individuals.

Growing elderly population across the globe is driving the market growth. According to the United Nations Population Fund’s India Ageing Report 2023, the population of individuals aged 60 and above is projected to double from 10.5% or 14.9 crore (as of July 1, 2022) to 20.8% or 34.7 crore by 2050. In addition, the World Health Organization in 2025 cited that the number of people aged 60 and above is expected to grow from 1.1 billion in 2023 to 1.4 billion by 2030. This demographic trend significantly drives demand in the elder care assistive robots market, as healthcare systems face rising pressure to provide continuous and efficient care.

Rising research and development activities in robotics are further fueling market growth. For instance, in January 2024, researchers at Cornell University's EmPRISE Lab introduced the RABBIT system, a robot-assisted bed bathing solution utilizing RGB and thermal imaging to identify skin conditions. It employs a compliant end-effector, "Scrubby," for gentle care, enhancing comfort and safety in personal hygiene tasks. A user study with 12 participants, including one with severe mobility limitations, demonstrated its effectiveness and perceived comfort. In addition, regulatory support and policy initiatives play a crucial role in fostering market growth. Supportive policies, such as funding for research and development, subsidies for technology adoption, and regulatory frameworks that ensure safety and efficacy, are boosting market growth.

Global Elder Care Assistive Robots Market Report Segmentation

This report forecasts revenue and volume growth at global, regional, and country level and provides an analysis on industry trends in each of the sub segments from 2021 to 2033. For the purpose of this study, Grand View Research, Inc. has segmented the global elder care assistive robots market report on the basis of type, functionality, and region:

Type Outlook (Revenue USD Million, 2021 - 2033)
Physically Assistive Robots
Socially Assistive Robots
Functionality Outlook (Revenue USD Million, 2021 - 2033)
Monitoring and Surveillance
Mobility Assistance
Social Interaction
Household Tasks
Regional Outlook Revenue USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
Spain
Italy
France
Denmark
Norway
Sweden
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Argentina
MEA
South Africa
Saudi Arabia
UAE
Kuwait

Please note The report will be delivered in 2-3 business days upon order notification.

Chapter 1. Methodology and Scope: 1.1. Market Segmentation & Scope; 1.1.1. Type of data; 1.1.2. End use; 1.1.3. Application; 1.1.4. Regional scope; 1.1.5. Estimates and forecast timeline.; 1.2. Research Methodology; 1.3. Information Procurement; 1.3.1. Purchased database.; 1.3.2. GVR’s internal database; 1.3.3. Secondary sources; 1.3.4. Primary research; 1.3.5. Details of primary research; 1.4. Information or Data Analysis; 1.4.1. Data analysis models; 1.5. Market Formulation & Validation; 1.6. Model Details; 1.6.1. Commodity flow analysis (Model 1); 1.6.2. Approach 1: Commodity flow approach; 1.6.3. Volume price analysis (Model 2); 1.6.4. Approach 2: Volume price analysis; 1.7. List of Secondary Sources; 1.8. List of Primary Sources; 1.9. Objectives
Chapter 2. Executive Summary: 2.1. Market Outlook; 2.2. Segment Outlook; 2.2.1. Type of data outlook; 2.2.2. End use outlook; 2.2.3. Application outlook; 2.2.4. Regional outlook; 2.3. Competitive Insights
Chapter 3. De-identified Health Data Market Variables, Trends & Scope: 3.1. Market Lineage Outlook; 3.1.1. Parent market outlook; 3.1.2. Related/ancillary market outlook; 3.2. Market Dynamics; 3.2.1. Market driver analysis; 3.2.2. Market restraint analysis; 3.2.3. Market Opportunity analysis; 3.3. De-identified Health Data Market Analysis Tools; 3.3.1. Industry Analysis - Porter’s; 3.3.1.1. Supplier power; 3.3.1.2. Buyer power; 3.3.1.3. Substitution threat; 3.3.1.4. Threat of new entrant; 3.3.1.5. Competitive rivalry; 3.3.2. PESTEL Analysis; 3.3.2.1. Political landscape; 3.3.2.2. Economic landscape; 3.3.2.3. Social landscape; 3.3.2.4. Technological landscape; 3.3.2.5. Environmental landscape; 3.3.2.6. Legal landscape
Chapter 4. De-identified Health Data Market: Type of Data Estimates & Trend Analysis: 4.1. Type of Data Market Share, 2025 & 2033; 4.2. Segment Dashboard; 4.3. Global De-identified Health Data Market by Type of Data Outlook; 4.4. Clinical Data; 4.4.1. Market estimates and forecast 2021 - 2033 (USD Million); 4.5. Genomic Data; 4.5.1. Market estimates and forecast 2021 - 2033 (USD Million); 4.6. Patient Demographics; 4.6.1. Market estimates and forecast 2021 - 2033 (USD Million); 4.7. Prescription Data; 4.7.1. Market estimates and forecast 2021 - 2033 (USD Million); 4.8. Claims Data; 4.8.1. Market estimates and forecast 2021 - 2033 (USD Million); 4.9. Behavioral Data; 4.9.1. Market estimates and forecast 2021 - 2033 (USD Million); 4.10. Wearable and Sensor Data; 4.10.1. Market estimates and forecast 2021 - 2033 (USD Million); 4.11. Survey and Patient-Reported Data; 4.11.1. Market estimates and forecast 2021 - 2033 (USD Million); 4.12. Imaging Data; 4.12.1. Market estimates and forecast 2021 - 2033 (USD Million); 4.13. Laboratory Data; 4.13.1. Market estimates and forecast 2021 - 2033 (USD Million); 4.14. Hospital and Provider Data; 4.14.1. Market estimates and forecast 2021 - 2033 (USD Million); 4.15. Social Determinants of Health (SDoH) Data; 4.15.1. Market estimates and forecast 2021 - 2033 (USD Million); 4.16. Pharmacogenomic Data; 4.16.1. Market estimates and forecast 2021 - 2033 (USD Million); 4.17. Biometric Data; 4.17.1. Market estimates and forecast 2021 - 2033 (USD Million); 4.18. Operational and Financial Data; 4.18.1. Market estimates and forecast 2021 - 2033 (USD Million); 4.19. Epidemiological Data; 4.19.1. Market estimates and forecast 2021 - 2033 (USD Million); 4.20. Healthcare Utilization Data; 4.20.1. Market estimates and forecast 2021 - 2033 (USD Million); 4.21. Others; 4.21.1. Market estimates and forecast 2021 - 2033 (USD Million)
Chapter 5. De-identified Health Data Market: End Use Estimates & Trend Analysis: 5.1. End Use Market Share, 2025 & 2033; 5.2. Segment Dashboard; 5.3. Global De-identified Health Data Market by End Use Outlook; 5.4. Pharmaceutical Companies; 5.4.1. Market estimates and forecast 2021 - 2033 (USD Million); 5.5. Biotechnology Firms; 5.5.1. Market estimates and forecast 2021 - 2033 (USD Million); 5.6. Medical Device Manufacturers; 5.6.1. Market estimates and forecast 2021 - 2033 (USD Million); 5.7. Healthcare Providers; 5.7.1. Market estimates and forecast 2021 - 2033 (USD Million); 5.8. Insurance Companies/ Healthcare Payers; 5.8.1. Market estimates and forecast 2021 - 2033 (USD Million); 5.9. Research Institutions; 5.9.1. Market estimates and forecast 2021 - 2033 (USD Million); 5.10. Government Agencies; 5.10.1. Market estimates and forecast 2021 - 2033 (USD Million); 5.11. Others; 5.11.1. Market estimates and forecast 2021 - 2033 (USD Million)
Chapter 6. De-identified Health Data Market: Application Estimates & Trend Analysis: 6.1. Application Market Share, 2025 & 2033; 6.2. Segment Dashboard; 6.3. Global De-identified Health Data Market by Application Outlook; 6.4. Clinical Research and Trials; 6.4.1. Market estimates and forecast 2021 - 2033 (USD Million); 6.5. Public Health; 6.5.1. Market estimates and forecast 2021 - 2033 (USD Million); 6.6. Precision Medicine; 6.6.1. Market estimates and forecast 2021 - 2033 (USD Million); 6.7. Health Economics and Outcomes Research (HEOR); 6.7.1. Market estimates and forecast 2021 - 2033 (USD Million); 6.8. Population Health Management; 6.8.1. Market estimates and forecast 2021 - 2033 (USD Million); 6.9. Drug Discovery and Development; 6.9.1. Market estimates and forecast 2021 - 2033 (USD Million); 6.10. Healthcare Quality Improvement; 6.10.1. Market estimates and forecast 2021 - 2033 (USD Million); 6.11. Insurance Underwriting and Risk Assessment; 6.11.1. Market estimates and forecast 2021 - 2033 (USD Million); 6.12. Market Access and Commercial Strategy; 6.12.1. Market estimates and forecast 2021 - 2033 (USD Million); 6.13. Business Intelligence and Operational Efficiency; 6.13.1. Market estimates and forecast 2021 - 2033 (USD Million); 6.14. Telemedicine and Remote Monitoring; 6.14.1. Market estimates and forecast 2021 - 2033 (USD Million); 6.15. Patient Engagement and Support Programs; 6.15.1. Market estimates and forecast 2021 - 2033 (USD Million); 6.16. Others; 6.16.1. Market estimates and forecast 2021 - 2033 (USD Million)
Chapter 7. De-identified Health Data Market: Regional Estimates & Trend Analysis, By Type of Data, By End use, By Application: 7.1. Regional Market Share Analysis, 2025 & 2033; 7.2. Regional Market Dashboard; 7.3. Global Regional Market Snapshot; 7.4. Market Size & Forecasts Trend Analysis, 2021 - 2033:; 7.5. North America; 7.5.1. U.S.; 7.5.1.1. Key country dynamics; 7.5.1.2. Regulatory framework/ reimbursement structure; 7.5.1.3. Competitive scenario; 7.5.1.4. U.S. market estimates and forecasts 2021 - 2033 (USD Million); 7.5.2. Canada; 7.5.2.1. Key country dynamics; 7.5.2.2. Regulatory framework/ reimbursement structure; 7.5.2.3. Competitive scenario; 7.5.2.4. Canada market estimates and forecasts 2021 - 2033 (USD Million); 7.5.3. Mexico; 7.5.3.1. Key country dynamics; 7.5.3.2. Regulatory framework/ reimbursement structure; 7.5.3.3. Competitive scenario; 7.5.3.4. Mexico market estimates and forecasts 2021 - 2033 (USD Million); 7.6. Europe; 7.6.1. UK; 7.6.1.1. Key country dynamics; 7.6.1.2. Regulatory framework/ reimbursement structure; 7.6.1.3. Competitive scenario; 7.6.1.4. UK market estimates and forecasts 2021 - 2033 (USD Million); 7.6.2. Germany; 7.6.2.1. Key country dynamics; 7.6.2.2. Regulatory framework/ reimbursement structure; 7.6.2.3. Competitive scenario; 7.6.2.4. Germany market estimates and forecasts 2021 - 2033 (USD Million); 7.6.3. France; 7.6.3.1. Key country dynamics; 7.6.3.2. Regulatory framework/ reimbursement structure; 7.6.3.3. Competitive scenario; 7.6.3.4. France market estimates and forecasts 2021 - 2033 (USD Million); 7.6.4. Italy; 7.6.4.1. Key country dynamics; 7.6.4.2. Regulatory framework/ reimbursement structure; 7.6.4.3. Competitive scenario; 7.6.4.4. Italy market estimates and forecasts 2021 - 2033 (USD Million); 7.6.5. Spain; 7.6.5.1. Key country dynamics; 7.6.5.2. Regulatory framework/ reimbursement structure; 7.6.5.3. Competitive scenario; 7.6.5.4. Spain market estimates and forecasts 2021 - 2033 (USD Million); 7.6.6. Norway; 7.6.6.1. Key country dynamics; 7.6.6.2. Regulatory framework/ reimbursement structure; 7.6.6.3. Competitive scenario; 7.6.6.4. Norway market estimates and forecasts 2021 - 2033 (USD Million); 7.6.7. Sweden; 7.6.7.1. Key country dynamics; 7.6.7.2. Regulatory framework/ reimbursement structure; 7.6.7.3. Competitive scenario; 7.6.7.4. Sweden market estimates and forecasts 2021 - 2033 (USD Million); 7.6.8. Denmark; 7.6.8.1. Key country dynamics; 7.6.8.2. Regulatory framework/ reimbursement structure; 7.6.8.3. Competitive scenario; 7.6.8.4. Denmark market estimates and forecasts 2021 - 2033 (USD Million); 7.7. Asia Pacific; 7.7.1. Japan; 7.7.1.1. Key country dynamics; 7.7.1.2. Regulatory framework/ reimbursement structure; 7.7.1.3. Competitive scenario; 7.7.1.4. Japan market estimates and forecasts 2021 - 2033 (USD Million); 7.7.2. China; 7.7.2.1. Key country dynamics; 7.7.2.2. Regulatory framework/ reimbursement structure; 7.7.2.3. Competitive scenario; 7.7.2.4. China market estimates and forecasts 2021 - 2033 (USD Million); 7.7.3. India; 7.7.3.1. Key country dynamics; 7.7.3.2. Regulatory framework/ reimbursement structure; 7.7.3.3. Competitive scenario; 7.7.3.4. India market estimates and forecasts 2021 - 2033 (USD Million); 7.7.4. Australia; 7.7.4.1. Key country dynamics; 7.7.4.2. Regulatory framework/ reimbursement structure; 7.7.4.3. Competitive scenario; 7.7.4.4. Australia market estimates and forecasts 2021 - 2033 (USD Million); 7.7.5. South Korea; 7.7.5.1. Key country dynamics; 7.7.5.2. Regulatory framework/ reimbursement structure; 7.7.5.3. Competitive scenario; 7.7.5.4. South Korea market estimates and forecasts 2021 - 2033 (USD Million); 7.7.6. Thailand; 7.7.6.1. Key country dynamics; 7.7.6.2. Regulatory framework/ reimbursement structure; 7.7.6.3. Competitive scenario; 7.7.6.4. Singapore market estimates and forecasts 2021 - 2033 (USD Million); 7.8. Latin America; 7.8.1. Brazil; 7.8.1.1. Key country dynamics; 7.8.1.2. Regulatory framework/ reimbursement structure; 7.8.1.3. Competitive scenario; 7.8.1.4. Brazil market estimates and forecasts 2021 - 2033 (USD Million); 7.8.2. Argentina; 7.8.2.1. Key country dynamics; 7.8.2.2. Regulatory framework/ reimbursement structure; 7.8.2.3. Competitive scenario; 7.8.2.4. Argentina market estimates and forecasts 2021 - 2033 (USD Million); 7.9. MEA; 7.9.1. South Africa; 7.9.1.1. Key country dynamics; 7.9.1.2. Regulatory framework/ reimbursement structure; 7.9.1.3. Competitive scenario; 7.9.1.4. South Africa market estimates and forecasts 2021 - 2033 (USD Million); 7.9.2. Saudi Arabia; 7.9.2.1. Key country dynamics; 7.9.2.2. Regulatory framework/ reimbursement structure; 7.9.2.3. Competitive scenario; 7.9.2.4. Saudi Arabia market estimates and forecasts 2021 - 2033 (USD Million); 7.9.3. UAE; 7.9.3.1. Key country dynamics; 7.9.3.2. Regulatory framework/ reimbursement structure; 7.9.3.3. Competitive scenario; 7.9.3.4. UAE market estimates and forecasts 2021 - 2033 (USD Million); 7.9.4. Kuwait; 7.9.4.1. Key country dynamics; 7.9.4.2. Regulatory framework/ reimbursement structure; 7.9.4.3. Competitive scenario; 7.9.4.4. Kuwait market estimates and forecasts 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape: 8.1. Recent Developments & Impact Analysis, By Key Market Participants; 8.2. Company/Competition Categorization; 8.3. Innovators; 8.4. Vendor Landscape; 8.4.1. List of key distributors and channel partners; 8.4.2. Key customers; 8.4.3. Key company market share analysis, 2025; 8.4.4. IQVIA; 8.4.4.1. Company overview; 8.4.4.2. Financial performance; 8.4.4.3. Technology Type benchmarking; 8.4.4.4. Strategic initiatives; 8.4.5. Oracle (Cerner Corporation); 8.4.5.1. Company overview; 8.4.5.2. Financial performance; 8.4.5.3. Technology Type benchmarking; 8.4.5.4. Strategic initiatives; 8.4.6. Optum, Inc. (UnitedHealth Group); 8.4.6.1. Company overview; 8.4.6.2. Financial performance; 8.4.6.3. Technology Type benchmarking; 8.4.6.4. Strategic initiatives; 8.4.7. ICON plc; 8.4.7.1. Company overview; 8.4.7.2. Financial performance; 8.4.7.3. Technology Type benchmarking; 8.4.7.4. Strategic initiatives; 8.4.8. Veradigm LLC (Formerly known as Allscripts); 8.4.8.1. Company overview; 8.4.8.2. Financial performance; 8.4.8.3. Technology Type benchmarking; 8.4.8.4. Strategic initiatives; 8.4.9. IBM; 8.4.9.1. Company overview; 8.4.9.2. Financial performance; 8.4.9.3. Technology Type benchmarking; 8.4.9.4. Strategic initiatives; 8.4.10. Flatiron Health (F. Hoffmann-La Roche Ltd); 8.4.10.1. Company overview; 8.4.10.2. Financial performance; 8.4.10.3. Technology Type benchmarking; 8.4.10.4. Strategic initiatives; 8.4.11. Premier, Inc.; 8.4.11.1. Company overview; 8.4.11.2. Financial performance; 8.4.11.3. Technology Type benchmarking; 8.4.11.4. Strategic initiatives; 8.4.12. Shaip; 8.4.12.1. Company overview; 8.4.12.2. Financial performance; 8.4.12.3. Technology Type benchmarking; 8.4.12.4. Strategic initiatives; 8.4.13. Komodo Health, Inc.; 8.4.13.1. Company overview; 8.4.13.2. Financial performance; 8.4.13.3. Technology Type benchmarking; 8.4.13.4. Strategic initiatives; 8.4.14. Evidation Health, Inc.; 8.4.14.1. Company overview; 8.4.14.2. Financial performance; 8.4.14.3. Technology Type benchmarking; 8.4.14.4. Strategic initiatives; 8.4.15. Medidata; 8.4.15.1. Company overview; 8.4.15.2. Financial performance; 8.4.15.3. Technology Type benchmarking; 8.4.15.4. Strategic initiatives; 8.4.16. Clarify Health Solutions; 8.4.16.1. Company overview; 8.4.16.2. Financial performance; 8.4.16.3. Technology Type benchmarking; 8.4.16.4. Strategic initiatives; 8.4.17. Satori Cyber Ltd.; 8.4.17.1. Company overview; 8.4.17.2. Financial performance; 8.4.17.3. Technology Type benchmarking; 8.4.17.4. Strategic initiatives

Pricing

Currency Rates

Single User Email from Publisher $5,950
Multi User License Fulfilled by Publisher $6,950
Global Site License Email from Publisher $8,950

How Do Licenses Work?

Request A Sample

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now